IBERDOMIDE AND DEXAMETHASONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Noemi Puig, 4160859

A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF SECONDARY IMMUNODEFICIENCY AND RISK OF INFECTION IN PATIENTS WITH AL AMYLOIDOSIS TREATED WITH DARATUMAMAB-BASED INDUCTION REGIMENS. A MULTICENTER ITALIAN EXPERIENCE

EHA Library, Anna Furlan, 4160860

RENAL RESPONSE AND PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT APPLYING VRD AND AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Chengcheng Fu, 4160864

THROMBOPROPHYLAXIS PRESCRIBING PATTERN AND RATES OF THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH MULTIPLE MYELOMA IN THE LARGEST HEALTHCARE SYSTEM IN NEW YORK

EHA Library, Phyu Thin Naing, 4160865

THE EFFICACY AND SAFETY OF DARATUMUMAB-BASED REGIMENS IN THE INITIAL TREATMENT OF AMYLOID LIGHT-CHAIN AMYLOIDOSIS

EHA Library, Kai Ding, 4160867

PHASE 3 DREAMM-10 STUDY DESIGN: BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE AND DEXAMETHASONE VS DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE NEWLY-DIAGNOSED MULTIPLE MYELOMA

EHA Library, Meletios Dimopoulos, 4160868

DECIPHERING BONE MARROW ENDOTHELIAL DYSFUNCTION IN MYELOPROLIFERATIVE NEOPLASMS THROUGH SPATIAL TRANSCRIPTOMICS

EHA Library, Jimena Castorena Rodriguez, 4160871

CHARACTERIZATION OF CD9 AS A NOVEL MARKER FOR DISEASE-PROPAGATING STEM CELLS IN MYELOFIBROSIS

EHA Library, Lara Tavernari, 4160872

THE IMMUNE-MODULATORY FUNCTION OF MEGAKARYOCYTES IN THE HEMATOPOIETIC NICHE OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Huichun Zhan, 4160873

REFINING MPN RISK STRATIFICATION USING AUGMENTED AI-DRIVEN BONE MARROW MORPHOLOGICAL ANALYSIS

EHA Library, Xuezi Hu, 4160874

TARGETED INHIBITION OF ACTIVATED NEUTROPHIL TRANSMIGRATION AMELIORATES MYELOPROLIFERATIVE NEOPLASM IN MICE

EHA Library, Sarolta Bojtiné Kovács, 4160879

CLINICAL AND GENE EXPRESSION PATTERNS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH LOW-RISK MYELOFIBROSIS ENROLLED IN THE MYELOFIBROSIS AND ESSENTIAL THROMBOCYTHEMIA OBSERVATIONAL STUDY (MOST)

EHA Library, Abdulraheem Yacoub, 4160883

IDENTIFICATION AND VALIDATION OF A NOVEL FERROPTOSIS-RELATED GENE SIGNATURE FOR PREDICTION OF THE PROGNOSIS IN PRIMARY MYELOFIBROSIS : BASED ON SINGLE-CELL ANALYSIS AND MACHINE LEARNING

EHA Library, Jian Huang, 4160884

THE COOPERATION BETWEEN CALRDEL52 AND TP53 MUTATIONS INCREASES THE NUMBER OF IMMATURE HEMATOPOIETIC PROGENITORS AND ENHANCES THROMBOPOIETIN-INDEPENDENT MEGAKARYOPOIESIS

EHA Library, Suzana Benedito, 4160885

ALLELIC POLYMORPHISMS IN KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENES MODULATE THE RISK FOR DEVELOPMENT OF PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Velizar Shivarov, 4160886

NOVEL INSIGHTS INTO THE INNATE IMMUNE LANDSCAPE OF MUTANT CALRETICULIN-DRIVEN MPN

EHA Library, Agnieszka Witalisz-Siepracka, 4160890

MOLECULAR DETERMINANTS OF RESISTANCE TO ROPEGINTERFERON ALFA-2B IN PV AND ET

EHA Library, Jihyun Song, 4160893

T CELL MATURATION SHIFT TOWARD A SENESCENT PROFILE AND ENHANCED INHIBITORY SIGNALING VIAREGULATORY T CELLS ARE ASSOCIATED WITH ADVANCED MYELOFIBROSIS

EHA Library, Camila Garcia, 4160894

A STUDY TO EVALUATE SINGLE-AGENT SELINEXOR VERSUS PHYSICIAN'S CHOICE IN PARTICIPANTS WITH PREVIOUSLY TREATED MYELOFIBROSIS

EHA Library, Alessandro Lucchesi, 4160896

SAFETY AND EFFICACY OF BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY

EHA Library, Pankit Vachhani, 4160897

CLINICAL AND MOLECULAR CHARACTERISTICS OF MYELOPROLIFERATIVE NEOPLASMS IN THE ADOLESCENTS AND YOUNG ADULTS POPULATION

EHA Library, Songyang Zhao, 4160898

DYNAMIC ELEVATIONS OF EARLY-STAGE MYELOID-DERIVED SUPPRESSOR CELLS PREDICT LEUKEMIC TRANSFORMATION IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOTILNIB: A REAL-WORLD, PROSPECTIVE, LONGITUDINAL STUDY

EHA Library, Jian Huang, 4160900

EXPLORATORY ANALYSIS OF GECACITINIB IN RUXOLITINIB-INTOLERANT MYELOFIBROSIS PATIENTS: IMPACT OF BASELINE ANEMIA AND PRIOR RUXOLITINIB TREATMENT DURATION ON RESPONSE TO GECACITINIB

EHA Library, Yi Zhang, 4160903

A PHASE 1/2A TRIAL OF PXS-5505, A NOVEL PAN-LYSYL OXIDASE INHIBITOR, IN PATIENTS WITH ADVANCED MYELOFIBROSIS

EHA Library, Anne-Marie Watson, 4160907

A PHASE 1 STUDY OF VAC85135, A NEOANTIGEN VACCINE REGIMEN TARGETING CALRETICULIN AND JAK2 MUTATIONS, IN COMBINATION WITH IPILIMUMAB (IPI) IN PATIENTS (PTS) WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS)

EHA Library, Salman Otoukesh, 4160910

RELATIONSHIP BETWEEN HEMOGLOBIN AND QUALITY OF LIFE IN NON-TRANSFUSION-DEPENDENT PATIENTS WITH MYELOFIBROSIS TREATED WITH LUSPATERCEPT

EHA Library, Haifa Kathrin Al-Ali, 4160916

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS TREATED WITH PACRITINIB (PAC) WITH PLATELETS ≥50 X109/L AT PAC INITIATION: INTERIM RESULTS FROM THE MY-PAC STUDY

EHA Library, Douglas Tremblay, 4160917

THE ECONOMIC BURDEN OF MYELOFIBROSIS TREATED WITH RUXOLITINIB IN FRANCE

EHA Library, Jean-Jacques KILADJIAN, 4160919

IMPACT OF INDIVIDUALIZED DOSING PROFILES OF MIDOSTAURIN ON SAFETY, RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Johannes Lübke, 4160921

PROGNOSTIC ASSESSMENT OF PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS IN THE RUXOLITINIB TREATMENT ERA

EHA Library, Ningning Liu, 4160923

QRISK3 SCORE IDENTIFIES ESSENTIAL THROMBOCYTHAEMIA AND POLYCYTHAEMIA VERA PATIENTS WHO BENEFIT FROM CYTOREDUCTIVE THERAPY

EHA Library, Andrea Duminuco, 4160926

ANEMIA RESPONSE IN PATIENTS WITH MYELOFIBROSIS TREATED WITH LUSPATERCEPT: A REAL-WORLD COHORT STUDY

EHA Library, Jesus D. Gonzalez-Lugo, 4160927

VALIDATION OF VENOUS THROMBOTIC SCORE (VETS) IN A CONSECUTIVE COHORT OF 335 PATIENTS DIAGNOSED WITH PH- MYELOPROLIFERATIVE NEOPLASM

EHA Library, Maria Helena Parrinello, 4160928

THE CHANGE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF HODGKIN LYMPHOMA IN NOVEL AGENT ERA.

EHA Library, Yukiko Misaki, 4160932

REAL-LIFE EVALUATION OF EFFICACY AND TOLERANCE OF A PET-GUIDED DE-ESCALATION FROM BRECADD TO BRAVD IN FIRST-LINE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA

EHA Library, Maxime Delforge, 4160934

AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER ANTI-PD-1 TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY RESULTS AND CHARACTERISTICS OF RELAPSES

EHA Library, Nikita Mochkin, 4160936

A SURVIVAL UPDATE ON A PHASE II TRIAL USING CONVENTIONAL CHEMOTHERAPY PLUS NIVOLUMAB IN ADVANCED STAGE HODGKIN DISEASE (HD)

EHA Library, Maher Salamoon, 4160941

THE ROLE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AND NIVOLUMAB IN RELAPSED AND REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ekaterina Fastova, 4160942

PROSPECTIVE MULTICENTER STUDY ON THE EFFECTIVENESS AND SAFETY OF PET-ADAPTED TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA USING ABVD AND EACODD-14 CHEMOTHERAPY REGIMENS (HL-RUSSIA-1): PRELIMINARY RESULTS ON EFFECTIVENESS AND PROGRESSION-FREE SURVIVAL

EHA Library, Nikita Shorokhov, 4160943

ZR STUDY: A PROSPECTIVE PHASE II CLINICAL TRIAL EVALUATING ZANUBRUTINIB-RITUXIMAB INDUCTION THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN TREATMENT-NAÏVE MANTLE CELL LYMPHOMA

EHA Library, Chang-Ju Qu, 4160945

OBINUTUZUMAB SINGLE AGENT FOR THE FIRST LINE TREATMENT OF MARGINAL ZONE LYMPHOMA: RESULTS OF THE PROSPECTIVE MULTICENTER PHASE II OLYMP-1 TRIAL OF THE GERMAN LYMPHOMA ALLIANCE (GLA)

EHA Library, Christian Buske, 4160947

THE IMPACT OF TIRABRUTINIB, A SECOND-GENARATION BRUTON'S TYROSINE KINASE INHIBITOR, FOR BING-NEEL SYNDROME: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Naohiro Sekiguchi, 4160949

LONG-TERM SURVIVAL TRENDS IN ADVANCED-STAGE MANTLE CELL LYMPHOMA: A POOLED ANALYSIS OF SIX RANDOMIZED PHASE III TRIALS FROM 1996 TO 2020

EHA Library, Linmiao Jiang, 4160950

TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A POST HOC ANALYSIS OF OUTCOMES BY POD24 STATUS FROM THE INMIND STUDY

EHA Library, Marek Trněný, 4160951

BIOMARKER ANALYSES OF THE INFLAMMATORY PROFILE AND MRD CLEARANCE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL) VERSUS FOLLICULAR LYMPHOMA (FL) TREATED WITH ODRONEXTAMAB

EHA Library, Geoffrey Chong, 4160952

BEXOBRUTIDEG (NX-5948), A NOVEL BRUTON'S TYROSINE KINASE DEGRADER, SHOWS HIGH CLINICAL ACTIVITY AND TOLERABLE SAFETY IN AN ONGOING PHASE 1A/B STUDY IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Dima El-Sharkawi, 4160957

IMPACT OF CORTICOSTEROIDS ON THE EFFICACY AND TOXICITY OF BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Cristian Gutierrez-Padilla, 4160861

INCIDENCE AND SURVIVAL OF MULTIPLE MYELOMA IN ENGLAND: AN UNSELECTED COHORT STUDY FROM THE UNCOVER STUDY GROUP AND UKMRA FRAILTY GROUP.

EHA Library, Thea Chandler, 4160862

IMPACT OF SALVAGE THERAPY ON OUTCOMES OF PATIENTS WITH FUNCTIONAL HIGH RISK MULTIPLE MYELOMA FROM THE HONEUR FEDERATED DATA NETWORK

EHA Library, Yael Cohen, 4160863

QUALITY OF PATIENT-REPORTED OUTCOME REPORTING IN MULTIPLE MYELOMA RANDOMIZED CONTROLLED TRIALS PROTOCOLS AND PUBLICATIONS ACCORDING TO THE SPIRIT-PRO AND CONSORT-PRO: A SYSTEMATIC REVIEW

EHA Library, Darshi Shah, 4160866

UNRAVELING THE MYELOFIBROTIC BONE MARROW NICHE: STROMAL AND IMMUNE INTERACTIONS AS POTENTIAL THERAPEUTIC TARGETS

EHA Library, Martina Crysandt, 4160869

SINGLE CELL MULTIOMIC ANALYSIS UNCOVERS MOLECULAR AND CLONAL EVENTS ASSOCIATED WITH RUXOLITINIB TREATMENT RESPONSE IN MYELOFIBROSIS

EHA Library, Sebastiano Rontauroli, 4160870

MED12L: A COMPONENT OF THE MEDIATOR COMPLEX AS A POTENTIAL NOVEL ORCHESTRATOR OF PLATELET DYSFUNCTION IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Matteo Brindisi, 4160875

EMBRYONIC HEMATOPOIETIC STEM AND PROGENITOR CELLS SHOW DIFFERENTIAL SUSCEPTIBILITY TO LEUKEMIC TRANSFORMATION UPON ACQUISITION OF JMML-ASSOCIATED KRASG12D MUTATION

EHA Library, Emanuele Azzoni, 4160876

GERMLINE VARIANTS IN MYELOPROLIFERATIVE NEOPLASMS WITH EARLY ONSET OR FAMILIAL HISTORY

EHA Library, Elisa Rumi, 4160877

APPLICATION OF WHOLE GENOME SEQUENCING IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN

EHA Library, Marina Gaskova, 4160878

INCB057643, A BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR, HAS NOVEL ROLES IN MYELOID CELL REGULATION AND IMMUNOSUPPRESSIVE TUMOUR ENVIRONMENT REMODELLING IN MYELOFIBROSIS

EHA Library, Hamza Celik, 4160880

A MOLECULAR SIGNATURE PREDICTS HEMATOLOGIC EVOLUTION IN POLYCYTHEMIA VERA PATIENTS, A FIM STUDY

EHA Library, Damien Luque Paz, 4160881

TUMOUR NEUTROPHIL DYSFUNCTION IN PRIMARY MYELOFIBROSIS: MITOCHONDRIAL IMPAIRMENT, OXIDATIVE STRESS, AND REDUCED ASCORBIC ACID PRODUCTION SHAPE THE BONE MARROW MICROENVIRONMENT

EHA Library, Enrico La Spina, 4160882

THERAPEUTIC STRATEGIES TARGETING SRSF2 AND KIT MUTATIONS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Ken-Hong Lim, 4160887

GLUTAMATE OVERLOAD IN THE MYELOFIBROSIS MICROENVIRONMENT RESHAPES MESENCHYMAL STROMAL CELLS' EPIGENETIC ARCHITECTURE TOWARD SENESCENCE.

EHA Library, Sebastiano Giallongo, 4160888

ANTI-HEMOJUVELIN MONOCLONAL ANTIBODY FURTHER ENHANCES HEMATOLOGIC RESPONSE TO ESA AND/OR LUSPATERCEPT IN MICE

EHA Library, Min Wu, 4160889

PRESENCE OF PERIPHERAL BLASTS PREDICT WORSE CLINICAL OUTCOMES IN PATIENTS WITH POLYCYTHEMIA VERA IRRESPECTIVE OF STANDARD RISK FACTORS

EHA Library, Lucia Masarova, 4160891

SOLUBLE ST2 AS A POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN SYSTEMIC MASTOCYTOSIS

EHA Library, Etnik Sheremeti, 4160892

IDENTIFICATION OF ULTRA HIGH-RISK GENOTYPES FOR PROGRESSION TO BLAST PHASE DISEASE REDEFINES MOLECULAR-BASED STRATIFICATION OF MYELOFIBROSIS

EHA Library, Noushin Farnoud, 4160895

CLINICAL TRAJECTORIES AND GENOMIC HETEROGENEITY IN AYA VERSUS NON-AYA ESSENTIAL THROMBOCYTHEMIA: A COMPARATIVE STUDY INTEGRATING CLINICAL PROFILES, OUTCOMES, AND NEXT-GENERATION SEQUENCING

EHA Library, Jian Huang, 4160899

DECODING THE MYELOPROLIFERATIVE NEOPLASM CONTINUUM: A MACHINE LEARNING APPROACH TO DISEASE EVOLUTION AND PROGNOSTIC STRATIFICATION

EHA Library, Yu-Hung WANG, 4160901

REAL-WORLD EFFECTIVENSS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS WHO HAVE THROMBOCYTOPENIA AND ANEMIA

EHA Library, Raajit K Rampal, 4160902

IMPACT OF DUAL SPLEEN RESPONSE AND TRANSFUSION INDEPENDENCE ON SURVIVAL IN JAK INHIBITOR-NAIVE PATIENTS WITH MYELOFIBROSIS AND ANEMIA TREATED WITH MOMELOTINIB: A SUBGROUP ANALYSIS OF SIMPLIFY-1

EHA Library, Francesca Palandri, 4160904

A PHASE I/II, OPEN-LABEL, MULTI-CENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF RUXOLITINIB AND CPX-351 IN COMBINATION FOR THE TREATMENT OF ADVANCED PHASE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Shivani Handa, 4160905

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH PRIMARY AND SECONDARY MYELOFIBROSIS TREATED WITH RUXOLITINIB: JUMP STUDY

EHA Library, Haifa Kathrin Al-Ali, 4160906

COMBINED CKIT D816V LIQUID BIOPSY AND HαT GENOTYPING: A NON-INVASIVE DIAGNOSTIC WORK-UP FOR THE SENSITIVE AND SPECIFIC DETECTION OF SYSTEMIC MASTOCYTOSIS

EHA Library, Daniel Koch, 4160908

DEVELOPMENT AND VALIDATIONTION OF A MODEL FOR PREDICTING LEUKEMIC TRANSFORMATION IN MYELOFIBROSIS PATIENTS A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Jian Huang, 4160909

EFFICACY OF LUSPATERCEPT IN TREATING ANEMIA IN SF3B1-POSITIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Minghui Duan, 4160911

FACTORS ASSOCIATED WITH GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Yuqian Sun, 4160912

INDIRECT TREATMENT COMPARISON OF GECACITINIB VS RUXOLITINIB IN MYELOFIBROSIS

EHA Library, Yi Zhang, 4160914

IMPACT OF THROMBOSIS ON DISEASE PROGRESSION, CANCER AND MORTALITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA

EHA Library, Alberto Alvarez Larran, 4160915

CLINICAL AND MOLECULAR DIAGNOSTIC CHALLENGES IN MYELOPROLIFERATIVE NEOPLASMS WITH LOW JAK2V617F ALLELIC BURDEN.

EHA Library, Erika Morsia, 4160918

DISC-0974 (AN ANTI-HEMOJUVELIN ANTIBODY) IN NON-TRANSFUSION-DEPENDENT PATIENTS WITH MYELOFIBROSIS: LABORATORY CORRELATES OF MAJOR ANEMIA RESPONSE

EHA Library, Ayalew Tefferi, 4160920

DEEP MOLECULAR RESPONSES WITH LOW-FIXED DOSE OF ROPEGINTERFERON ALFA-2B IN A ROLLOVER COHORT OF THE LOW-PV TRIAL

EHA Library, Tiziano Barbui, 4160922

THE APPLICABILITY OF CLINICAL, CYTOGENETIC, AND MOLECULAR PREDICTORS OF OUTCOME IN PATIENTS WITH MYELOFIBROSIS IN THE ERA OF JAK INHIBITORS

EHA Library, Haifa Kathrin Al-Ali, 4160924

NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN MYELOPROLIFERATIVE NEOPLASMS (MPNS): IMPACT OF CYTOREDUCTIVE THERAPY

EHA Library, Elena Torre, 4160925

AN EXPLORATORY ANALYSIS OF SYMPTOMATIC BENEFIT IN PATIENTS TREATED WITH GECACITINIB: A FOCUS ON THOSE INTOLERANT OR REFRACTORY/RELAPSED TO RUXOLITINIB

EHA Library, Yi Zhang, 4160929

DIFFERENTIAL IMPACTS OF GRAFT-VERSUS-HOST DISEASE ON SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA ACCORDING TO TRANSPLANT MODALITIES

EHA Library, Hidehiro Itonaga, 4160930

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER CHECKPOINT INHIBITORS IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS: A RETROSPECTIVE ANALYSIS OF THE EBMT-LWP (CHECK-AUTO STUDY)

EHA Library, Carmen Martinez, 4160931

IMPACT OF AGE, FRAILTY AND COMORBIDITIES IN THE SURVIVAL OF OLDER PATIENTS WITH HODGKIN LYMPHOMA: A RETROSPECTIVE, MULTICENTER STUDY IN SPAIN FROM THE SPANISH LYMPHOMA REGISTRY (RELINF) OF THE SPANISH GROUP OF LYMPHOMA (GELTAMO)

EHA Library, Raul Cordoba, 4160933

EFFICACY AND SAFETY OF PEMBROLIZUMAB EVERY 6 WEEKS IN RELAPSED/REFRACTORY (R/R) CLASSIC HODGKIN LYMPHOMA (CHL) OR PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL): UPDATED ANALYSIS FROM KEYNOTE-B68

EHA Library, Wojciech Jurczak, 4160935

METABOLIC TUMOR VOLUME IN OLDER PATIENTS WITH ADVANCED-STAGE CLASSIC HODGKIN LYMPHOMA: RESULTS FROM THE GHSG HD21 TRIAL

EHA Library, Paul J. Bröckelmann, 4160937

OUTCOMES OF ADOLESCENT AND YOUNG ADULT PATIENTS WITH HODGKIN LYMPHOMA (HL): A SINGLE-CENTER EXPERIENCE

EHA Library, Athanasios Liaskas, 4160938

FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1 STUDY OF CD30-DIRECTED ANTIBODY DRUG CONJUGATE, PF-08046044 (35C), IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMAS: DOSE ESCALATION SAFETY AND PRELIMINARY EFFICACY

EHA Library, Christina Poh, 4160939

REAL-WORLD EVIDENCE OF BRENTUXIMAB VEDOTIN (BV) CONSOLIDATION AFTER AUTOLOGOUS TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RRHL): 2-YEAR FOLLOW-UP OF GATLA RRHL STUDY

EHA Library, Astrid Pavlovsky, 4160940

PD-1-BASED SALVAGE THERAPY FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA: A MULTICENTER REAL-WORLD ANALYSIS

EHA Library, Hishan Tharmaseelan, 4160944

FIXED-DURATION SUBCUTANEOUS MOSUNETUZUMAB DEMONSTRATES CLINICALLY RELEVANT EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH HIGH-RISK FEATURES: PIVOTAL PHASE II STUDY UPDATE

EHA Library, Georg Heß, 4160946

GOLDILOX: FIRST EXPERIENCE OF SAFETY AND ACTIVITY OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA IN PATIENTS PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS - AN ALLG STUDY

EHA Library, Chan Y. Cheah, 4160948

GOLCADOMIDE (GOLCA), A CEREBLON E3 LIGASE MODULATOR (CELMOD™) AGENT ± RITUXIMAB (R), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): UPDATED PHASE 1/2 STUDY RESULTS

EHA Library, Raul Cordoba, 4160953

BARRIERS FOR TRIAL INCLUSION AND IMPACT ON SURVIVAL FOR MANTLE CELL LYMPHOMA PATIENTS WITHIN AND OUTSIDE OF THE RANDOMIZED PHASE II/III TRIAL ENRICH

EHA Library, Leila Boukharta, 4160954

LONG-TERM FOLLOW-UP OF VENETOCLAX MONOTHERAPY IN PREVIOUSLY TREATED PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jorge Castillo, 4160955

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE

EHA Library, Morgane Cheminant, 4160956

PROGNOSTIC IMPACT OF POD24 AND MALT-IPI ON OVERALL SURVIVAL IN EXTRANODAL MARGINAL ZONE LYMPHOMA RECEIVING SYSTEMIC CHEMOTHERAPY: ANALYSIS FROM THE THAI LYMPHOMA STUDY GROUP (TLSG)

EHA Library, Kannadit Prayongratana, 4160958

DETERMINING THE PROGNOSTIC SIGNIFICANCE OF THE KI67 PROLIFERATION INDEX IN TREATMENT-NAÏVE FOLLICULAR LYMPHOMA: AN AUSTRALASIAN LYMPHOMA AND RELATED DISEASES REGISTRY (LARDR) STUDY

EHA Library, Eliza Chung, 4160959